Remove 2002 Remove Clinical Trials Remove Concentrates Remove Consumption
article thumbnail

Best strains and terpenes for focus and flow state

The Cannigma

A flow state is when all of your attention is concentrated on the task at hand, to the point that the world outside flows away. But this isn’t the only area of the brain affected by cannabis consumption. A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. How cannabis can help with focus.

Terpenes 118
article thumbnail

Best strains and terpenes for creativity

The Cannigma

A side effect of cannabis consumption is increased blood flow, particularly in the brain. A 2002 study found that smoking cannabis increased blood flow in the frontal lobe, an area that’s thought to play an important role in abstract thought, creative thinking and sensory processing.

Terpenes 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

In time, Western civilization caught on, and consumption expanded around the globe. Responsible consumption is key, and in the case of psychedelics – where you could potentially become detached from reality – it’s important to be in a safe space, preferably around people you’re comfortable with.

History 119
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al. 7) and 2018 ( n ?=?4),

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2002 Jun;42(8):993-1007.